March 12, 2020 / 7:17 AM / a month ago

BRIEF-STADA Arzneimittel FY EBITDA Up 15% To EUR 612.8 Million

March 12 (Reuters) - STADA Arzneimittel AG:

* 24% RISE IN ADJUSTED EBITDA TO EUR 625.5 MILLION IN ITS 2019

* STADA REPORTED 12% GROWTH IN FY GROUP SALES TO EUR 2.61 BILLION

* FY REPORTED EBITDA FOR 12 MONTHS TO DECEMBER 31 2019 INCREASED BY 15% TO EUR 612.8 MILLION (2018: EUR 530.6 MILLION) Source text: bit.ly/2TGfk7Y Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below